Press Release from Emulate


Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug. 4, 2020-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an immuno-oncology company focused on bispecific antibody development, today announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets.

Please find the full press release here:

Posted: 24-Sep-2020

United States
3475135304 Main website

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021